Henry Schein Inc - HSIC STOCK NEWS

Henry Schein (NASDAQ: HSIC) will sponsor keynote speaker Erica Dhawan at the 2023 Women in DSO® event from March 8-10, 2023, in Las Vegas. Dhawan, a renowned authority on collaboration and innovation, will speak on March 9. As a founding supporter of Women in DSO®, Henry Schein aims to promote female leadership in the dental sector. The company emphasizes creating an inclusive environment by partnering with organizations that align with this mission. Notably, Henry Schein was awarded the Women’s Choice Award for Best Companies to Work For, reflecting its commitment to diversity and empowerment.

Henry Schein, Inc. (Nasdaq: HSIC) hosted an Investor Meeting in New York City to present its BOLD+1 Strategic Plan aimed at sustainable growth and long-term financial goals. CEO Stanley Bergman highlighted the company's transformation since 1995 into a leading global health care distribution provider. The plan focuses on digital transformation, revenue growth in specialty products, and ESG investments. Management discussed recent financial guidance and market growth opportunities, affirming their commitment to shareholder value. The event was streamed live, with materials available on their investor relations website.

Henry Schein, along with its dental laboratory business Zahn Dental, is actively participating in key events at the Chicago Dental Society Midwinter Meeting. The agenda includes a keynote presentation by Stanley M. Bergman, focused on growth drivers like dental implants and advancements in technology, including 3D printing. The events aim to enhance relationships with dental laboratories and support digital adoption. Attendees will benefit from educational sessions, product demonstrations, and discussions on integrating digital workflows. Zahn Dental expects to reach over 1,000 lab technicians at the LMT LAB DAY, providing hands-on experience with innovations like the 3D printer TRUJETX3™.

Henry Schein (Nasdaq: HSIC) announced its participation in the Barclays Global Healthcare Conference on March 14, 2023, at 1:35 p.m. Eastern time in Miami, Florida. This conference will showcase Henry Schein's role as the world’s largest provider of health care solutions for office-based dental and medical practitioners. Investors can access the presentation through a live webcast on the company's website, which will be available for replay afterward. With over 22,000 Team Schein Members, Henry Schein offers more than 300 solutions supporting 1 million customers, highlighting a sales revenue of $12.6 billion in 2022.

Henry Schein (NASDAQ: HSIC) showcased a comprehensive array of products at the 2023 Chicago Dental Society Midwinter meeting, aimed at enhancing practice efficiency for oral health professionals. The presentation included innovative technology solutions and new products such as the CARINA Digital Intraoral Sensors. Attendees were invited to explore a wide range of digital equipment, practice management software, and financial services designed to optimize workflows and improve patient experiences. Henry Schein's focus on delivering a customer-centric approach reflects their commitment to integrating digital solutions within dental practices.

Henry Schein reported fourth-quarter 2022 net sales of $3.4 billion, reflecting a 1.2% increase versus Q4 2021. GAAP diluted EPS fell to $0.34 compared to $1.05 in the prior year, while non-GAAP diluted EPS rose to $1.21 from $1.07. Notably, internal sales grew 5.0% when excluding the impact of PPE and COVID-19 products. Guidance for 2023 non-GAAP EPS is set at $5.25 to $5.42, forecasting a -2% to +1% growth from 2022 non-GAAP EPS. The company also anticipates a 30% to 35% decline in PPE and COVID-19 product sales compared to 2022.

Henry Schein announced a new share repurchase program authorized by its Board of Directors, allowing the buyback of up to $400 million of common stock. This plan complements a previous $400 million repurchase program from August 2022, expected to conclude by the end of the first quarter of 2023. With approximately 131.5 million shares outstanding, the new authorization accounts for about 3.8% of total shares. The program underscores the company’s confidence in its BOLD +1 Strategic Plan and financial stability, which enables it to invest in growth while enhancing shareholder value.

Henry Schein, Inc. (NASDAQ: HSIC) recently opened the Nasdaq Stock Market to highlight its commitment to public-private partnerships aimed at enhancing health equity. Key initiatives like Give Kids A Smile and Release the Pressure were showcased, emphasizing the company's efforts in providing quality care to underserved populations. CEO Stanley M. Bergman remarked on the importance of these collaborations in identifying health care inequities. With over 22,000 team members and a global presence, Henry Schein has served one million customers, demonstrating its dedication to improving health care access and outcomes.

Over the past 21 years, the Give Kids A Smile (GKAS) program has provided free oral health education and services to more than seven million underserved children in the U.S. Launched in 2003, this year’s initiative includes nearly 1,200 events aimed at reaching an estimated 300,000 children. Approximately 30,000 dental professionals will volunteer, utilizing essential oral care products donated by national sponsors Colgate-Palmolive (NYSE: CL) and Henry Schein (NASDAQ: HSIC). Since 2007, Colgate has exclusively supported GKAS, while Henry Schein has contributed over $20 million in products, ensuring access to quality dental care for children in need.